Northland Securities Initiates Coverage on Luminex (LMNX) with an Outperform
More News related to LMNX
- Luminex (LMNX) Misses Street's Q3 Views; Guides FY09
- Luminex Corporation Reports Third Quarter 2009 Results
- Trading Radar for 11/04: Cisco (CSCO), Comcast (CMCSA), Tyco (TEL), Molson Coors (TAP) Report
- Luminex Corporation Third Quarter Earnings Release Scheduled for November 4, 2009
- Luminex Corporation Launches New xTAGRVP.com Respiratory Virus Testing and Information Website
More News related to New Coverage
- Sidoti & Co Initiates Coverage on Stratasys (SSYS) with a Neutral
- ThinkEquity Initiates Coverage on Sourcefire (FIRE) with a Buy
- Raymond James Initiates Coverage on Knight Capital (NITE) with a Market Perform
- Raymond James Initiates Coverage on International Game Technology (IGT) with a Market Perform
- Thomas Weisel Initiates Coverage on UQM Technologies (UQM) with an Overweight
Northland Securities initiates coverage on Luminex (Nasdaq: LMNX) with an Outperform. Price target $19.25.
To see more analyst ratings on LMNX Click Here.
Luminex Corporation develops, manufactures and sells biological testing technologies and products with applications throughout the life sciences and diagnostic industries.
Related Categories
New CoverageStocks Mentioned
-0.29Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
